Cipher Pharmaceuticals Inc. (TSX:CPH)

Cipher Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6.41	7.49	17.84	39.83	28.84	20.55
Cash & Short-Term Investments	6.41	7.49	17.84	39.83	28.84	20.55
Cash Growth	-70.86%	-57.99%	-55.21%	38.11%	40.34%	124.76%
Accounts Receivable	9.75	11.21	13.86	5.09	6.8	6.66
Inventory	8.2	8.19	5.79	2.98	2.15	1.65
Other Current Assets	1.14	1.16	1	0.38	0.37	0.47
Total Current Assets	25.5	28.05	38.48	48.27	38.16	29.33
Net Property, Plant & Equipment	0.48	0.57	0.68	0.4	0.48	0.5
Other Intangible Assets	70.85	72.01	78.75	1.76	2.75	3.65
Goodwill	17.45	17.45	17.45	15.71	15.71	15.71
Other Long-Term Assets	39.01	38.43	27.15	19.89	16.67	2.47
Total Assets	153.28	156.5	162.51	86.03	73.78	51.65

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.5	6.39	5.87	4.6	4.11	5.56
Current Portion of Leases	0.26	0.29	0.28	0.09	0.1	0.06
Unearned Revenue	13.6	18.35	13.31	0.56	0.26	0.45
Other Current Liabilities	0.01	0.01	0.41	-	4.9	6.23
Total Current Liabilities	20.37	25.04	19.87	5.25	9.37	12.29
Long-Term Debt	-	5	40	-	-	-
Long-Term Leases	0.17	0.22	0.3	0.26	0.33	0.46
Total Long-Term Liabilities	0.17	5.22	40.3	0.26	0.33	0.46
Total Liabilities	20.53	30.26	60.17	5.51	9.7	12.75

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	28.1	27.86	27.68	18.01	17.72	18.12
Additional Paid-in Capital	7.89	7.79	6.53	5.76	5.36	5.09
Accumulated Other Comprehensive Income	-9.51	-9.51	-9.51	-9.51	-9.51	-9.51
Retained Earnings	106.28	100.11	77.65	66.27	50.52	25.2
Shareholders' Equity	132.75	126.24	102.34	80.52	64.08	38.9
Total Liabilities & Equity	153.28	156.5	162.51	86.03	73.78	51.65

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.43	5.51	40.58	0.35	0.43	0.52
Net Cash (Debt)	5.98	1.99	-22.74	39.47	28.41	20.03
Net Cash Growth	-	-	-	38.95%	41.81%	174.67%
Net Cash Per Share	0.23	0.08	-0.90	1.55	1.10	0.75
Book Value	132.75	126.24	102.34	80.52	64.08	38.9
Book Value Per Share	5.07	4.86	4.06	3.17	2.48	1.45
Tangible Book Value	44.45	36.78	6.14	63.05	45.62	19.54
Tangible Book Value Per Share	1.70	1.42	0.24	2.48	1.77	0.73

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 7, 2026

Data Sources Report a data error